Brenus Pharma
PrivateLast Round
Series A
Jul 30, 2026
Total Funding Raised
$47.47M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Brenus Pharma is a clinical-stage biotechnology company that develops allogeneic cancer vaccines using its proprietary 'Stimulated-Tumor-(ghost)-Cells' (STC) platform to educate the immune system to target and destroy cancer cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brenus Pharma Comparables
Compare Brenus Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Imvax | 80% | |
| NEUVOGEN, Inc. | 79% | |
| PDC*line Pharma | 79% | |
Brenus Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 30, 2026 | ||||
| Series A | Sep 18, 2024 | ||||
| Grant | Jan 22, 2024 | ||||
| Seed | Mar 17, 2022 |
Key People
Founding team and executive leadership
Brenus Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noshaq | Series A |
| Investsud | Series A |
| Kreaxi | Series A |
| Korea Omega Investment Corp | Series A |
| Financière Spin-off Luxembourgeoise | Series A |
| French Ministry of the Economy, Finance and Industrial and Digital Sovereignty | Grant |
| Angelor | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2026
$13M round with UI Investissement and Angelor
- Jul 1, 2026
Grew 17% QoQ, from 24 to 28 employees.
Brenus Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Brenus Pharma's valuation, stock price, and market status.